Keyword: Ipsen Pharmaceuticals


Ex-Baxalta exec Meek takes CEO reins at Ipsen

France’s Ipsen has pledged it will get nearly a third of its revenue out of the U.S. by 2020 and has named American and pharma vet David Meek its new CEO to see that that happens. Meek recently lost his job as the former head of oncology at Baxalta when Shire last month closed its buyout of the Baxter spinoff.